nodes	percent_of_prediction	percent_of_DWPC	metapath
Lubiprostone—CLCN2—endothelium—brain cancer	0.0995	0.186	CbGeAlD
Lubiprostone—CLCN2—blood vessel—brain cancer	0.0918	0.172	CbGeAlD
Lubiprostone—CLCN2—gonad—brain cancer	0.0372	0.0696	CbGeAlD
Lubiprostone—CLCN2—pituitary gland—brain cancer	0.0363	0.0679	CbGeAlD
Lubiprostone—CLCN2—spinal cord—brain cancer	0.0312	0.0585	CbGeAlD
Lubiprostone—CLCN2—endocrine gland—brain cancer	0.0281	0.0526	CbGeAlD
Lubiprostone—CLCN2—head—brain cancer	0.0277	0.0519	CbGeAlD
Lubiprostone—CLCN2—cerebellum—brain cancer	0.0247	0.0463	CbGeAlD
Lubiprostone—CLCN2—brain—brain cancer	0.0201	0.0376	CbGeAlD
Lubiprostone—CBR1—telencephalon—brain cancer	0.0178	0.0334	CbGeAlD
Lubiprostone—CBR1—gonad—brain cancer	0.0149	0.0279	CbGeAlD
Lubiprostone—CBR1—pituitary gland—brain cancer	0.0145	0.0272	CbGeAlD
Lubiprostone—CBR1—medulla oblongata—brain cancer	0.014	0.0263	CbGeAlD
Lubiprostone—CBR1—midbrain—brain cancer	0.0128	0.024	CbGeAlD
Lubiprostone—CBR1—spinal cord—brain cancer	0.0125	0.0234	CbGeAlD
Lubiprostone—Faecal incontinence—Carmustine—brain cancer	0.0121	0.0259	CcSEcCtD
Lubiprostone—Faecal incontinence—Temozolomide—brain cancer	0.0117	0.025	CcSEcCtD
Lubiprostone—Lethargy—Lomustine—brain cancer	0.0114	0.0243	CcSEcCtD
Lubiprostone—CBR1—endocrine gland—brain cancer	0.0113	0.0211	CbGeAlD
Lubiprostone—CBR1—head—brain cancer	0.0111	0.0208	CbGeAlD
Lubiprostone—CBR1—central nervous system—brain cancer	0.0101	0.019	CbGeAlD
Lubiprostone—CBR1—cerebellum—brain cancer	0.00992	0.0186	CbGeAlD
Lubiprostone—Throat tightness—Etoposide—brain cancer	0.0096	0.0206	CcSEcCtD
Lubiprostone—CBR1—brain—brain cancer	0.00805	0.0151	CbGeAlD
Lubiprostone—Lethargy—Procarbazine—brain cancer	0.00721	0.0155	CcSEcCtD
Lubiprostone—Pollakiuria—Procarbazine—brain cancer	0.00564	0.0121	CcSEcCtD
Lubiprostone—Pain—Carboplatin—brain cancer	0.00534	0.0115	CcSEcCtD
Lubiprostone—Chest discomfort—Etoposide—brain cancer	0.00532	0.0114	CcSEcCtD
Lubiprostone—Anorexia—Lomustine—brain cancer	0.00521	0.0112	CcSEcCtD
Lubiprostone—Swelling—Carmustine—brain cancer	0.00501	0.0107	CcSEcCtD
Lubiprostone—Decreased appetite—Lomustine—brain cancer	0.00475	0.0102	CcSEcCtD
Lubiprostone—Weight increased—Hydroxyurea—brain cancer	0.0043	0.00922	CcSEcCtD
Lubiprostone—Tremor—Procarbazine—brain cancer	0.00398	0.00854	CcSEcCtD
Lubiprostone—Swelling—Etoposide—brain cancer	0.00387	0.00831	CcSEcCtD
Lubiprostone—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.00384	0.00825	CcSEcCtD
Lubiprostone—Syncope—Procarbazine—brain cancer	0.00381	0.00818	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00377	0.00808	CcSEcCtD
Lubiprostone—Loss of consciousness—Procarbazine—brain cancer	0.00374	0.00802	CcSEcCtD
Lubiprostone—Abdominal distension—Temozolomide—brain cancer	0.00371	0.00797	CcSEcCtD
Lubiprostone—Cough—Procarbazine—brain cancer	0.00371	0.00796	CcSEcCtD
Lubiprostone—Myalgia—Procarbazine—brain cancer	0.00362	0.00776	CcSEcCtD
Lubiprostone—Anxiety—Procarbazine—brain cancer	0.00361	0.00774	CcSEcCtD
Lubiprostone—Dry mouth—Procarbazine—brain cancer	0.00354	0.00759	CcSEcCtD
Lubiprostone—Vomiting—Lomustine—brain cancer	0.00348	0.00745	CcSEcCtD
Lubiprostone—Oedema—Procarbazine—brain cancer	0.00347	0.00744	CcSEcCtD
Lubiprostone—Shock—Procarbazine—brain cancer	0.00341	0.00732	CcSEcCtD
Lubiprostone—Pollakiuria—Temozolomide—brain cancer	0.00341	0.00731	CcSEcCtD
Lubiprostone—Tachycardia—Procarbazine—brain cancer	0.00339	0.00726	CcSEcCtD
Lubiprostone—Weight increased—Temozolomide—brain cancer	0.00336	0.0072	CcSEcCtD
Lubiprostone—Hyperhidrosis—Procarbazine—brain cancer	0.00336	0.0072	CcSEcCtD
Lubiprostone—Urinary tract infection—Carmustine—brain cancer	0.00331	0.0071	CcSEcCtD
Lubiprostone—Anorexia—Procarbazine—brain cancer	0.00331	0.0071	CcSEcCtD
Lubiprostone—Erythema—Hydroxyurea—brain cancer	0.00329	0.00706	CcSEcCtD
Lubiprostone—Nausea—Lomustine—brain cancer	0.00325	0.00696	CcSEcCtD
Lubiprostone—Urinary tract infection—Temozolomide—brain cancer	0.0032	0.00686	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00316	0.00678	CcSEcCtD
Lubiprostone—Cramp muscle—Etoposide—brain cancer	0.00308	0.0066	CcSEcCtD
Lubiprostone—Ill-defined disorder—Hydroxyurea—brain cancer	0.00305	0.00655	CcSEcCtD
Lubiprostone—Decreased appetite—Procarbazine—brain cancer	0.00302	0.00647	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Etoposide—brain cancer	0.00301	0.00646	CcSEcCtD
Lubiprostone—Oedema peripheral—Carmustine—brain cancer	0.00301	0.00646	CcSEcCtD
Lubiprostone—Connective tissue disorder—Carmustine—brain cancer	0.003	0.00644	CcSEcCtD
Lubiprostone—Fatigue—Procarbazine—brain cancer	0.00299	0.00642	CcSEcCtD
Lubiprostone—Malaise—Hydroxyurea—brain cancer	0.00297	0.00637	CcSEcCtD
Lubiprostone—Pain—Procarbazine—brain cancer	0.00297	0.00637	CcSEcCtD
Lubiprostone—Constipation—Procarbazine—brain cancer	0.00297	0.00637	CcSEcCtD
Lubiprostone—Oedema peripheral—Temozolomide—brain cancer	0.00291	0.00624	CcSEcCtD
Lubiprostone—Connective tissue disorder—Temozolomide—brain cancer	0.0029	0.00622	CcSEcCtD
Lubiprostone—Feeling abnormal—Procarbazine—brain cancer	0.00286	0.00613	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Procarbazine—brain cancer	0.00284	0.00609	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00278	0.00597	CcSEcCtD
Lubiprostone—Discomfort—Hydroxyurea—brain cancer	0.00277	0.00594	CcSEcCtD
Lubiprostone—Abdominal pain—Procarbazine—brain cancer	0.00274	0.00588	CcSEcCtD
Lubiprostone—Oedema—Hydroxyurea—brain cancer	0.00269	0.00576	CcSEcCtD
Lubiprostone—Mental disorder—Carmustine—brain cancer	0.00268	0.00574	CcSEcCtD
Lubiprostone—Mediastinal disorder—Temozolomide—brain cancer	0.00266	0.00571	CcSEcCtD
Lubiprostone—Erythema—Carmustine—brain cancer	0.00266	0.00571	CcSEcCtD
Lubiprostone—Malnutrition—Carmustine—brain cancer	0.00266	0.00571	CcSEcCtD
Lubiprostone—Nervous system disorder—Hydroxyurea—brain cancer	0.00263	0.00565	CcSEcCtD
Lubiprostone—Skin disorder—Hydroxyurea—brain cancer	0.00261	0.0056	CcSEcCtD
Lubiprostone—Mental disorder—Temozolomide—brain cancer	0.00259	0.00555	CcSEcCtD
Lubiprostone—Malnutrition—Temozolomide—brain cancer	0.00257	0.00551	CcSEcCtD
Lubiprostone—Erythema—Temozolomide—brain cancer	0.00257	0.00551	CcSEcCtD
Lubiprostone—Anorexia—Hydroxyurea—brain cancer	0.00256	0.00549	CcSEcCtD
Lubiprostone—Hypersensitivity—Procarbazine—brain cancer	0.00256	0.00548	CcSEcCtD
Lubiprostone—Dysgeusia—Temozolomide—brain cancer	0.00252	0.0054	CcSEcCtD
Lubiprostone—Tremor—Carmustine—brain cancer	0.00249	0.00535	CcSEcCtD
Lubiprostone—Asthenia—Procarbazine—brain cancer	0.00249	0.00534	CcSEcCtD
Lubiprostone—Tremor—Temozolomide—brain cancer	0.00241	0.00517	CcSEcCtD
Lubiprostone—Dyspnoea—Hydroxyurea—brain cancer	0.00239	0.00514	CcSEcCtD
Lubiprostone—Ill-defined disorder—Temozolomide—brain cancer	0.00239	0.00512	CcSEcCtD
Lubiprostone—Diarrhoea—Procarbazine—brain cancer	0.00237	0.00509	CcSEcCtD
Lubiprostone—Dyspepsia—Hydroxyurea—brain cancer	0.00236	0.00507	CcSEcCtD
Lubiprostone—Decreased appetite—Hydroxyurea—brain cancer	0.00234	0.00501	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00232	0.00497	CcSEcCtD
Lubiprostone—Malaise—Temozolomide—brain cancer	0.00232	0.00497	CcSEcCtD
Lubiprostone—Fatigue—Hydroxyurea—brain cancer	0.00232	0.00497	CcSEcCtD
Lubiprostone—Pain—Hydroxyurea—brain cancer	0.0023	0.00493	CcSEcCtD
Lubiprostone—Constipation—Hydroxyurea—brain cancer	0.0023	0.00493	CcSEcCtD
Lubiprostone—Dizziness—Procarbazine—brain cancer	0.0023	0.00492	CcSEcCtD
Lubiprostone—Palpitations—Temozolomide—brain cancer	0.00227	0.00487	CcSEcCtD
Lubiprostone—Myalgia—Carmustine—brain cancer	0.00227	0.00486	CcSEcCtD
Lubiprostone—Chest pain—Carmustine—brain cancer	0.00227	0.00486	CcSEcCtD
Lubiprostone—Anxiety—Carmustine—brain cancer	0.00226	0.00484	CcSEcCtD
Lubiprostone—Cough—Temozolomide—brain cancer	0.00224	0.00481	CcSEcCtD
Lubiprostone—Feeling abnormal—Hydroxyurea—brain cancer	0.00221	0.00475	CcSEcCtD
Lubiprostone—Vomiting—Procarbazine—brain cancer	0.00221	0.00473	CcSEcCtD
Lubiprostone—Myalgia—Temozolomide—brain cancer	0.00219	0.00469	CcSEcCtD
Lubiprostone—Rash—Procarbazine—brain cancer	0.00219	0.00469	CcSEcCtD
Lubiprostone—Dermatitis—Procarbazine—brain cancer	0.00219	0.00469	CcSEcCtD
Lubiprostone—Anxiety—Temozolomide—brain cancer	0.00218	0.00468	CcSEcCtD
Lubiprostone—Headache—Procarbazine—brain cancer	0.00217	0.00466	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00217	0.00466	CcSEcCtD
Lubiprostone—Oedema—Carmustine—brain cancer	0.00217	0.00466	CcSEcCtD
Lubiprostone—Discomfort—Temozolomide—brain cancer	0.00216	0.00464	CcSEcCtD
Lubiprostone—Dry mouth—Temozolomide—brain cancer	0.00214	0.00459	CcSEcCtD
Lubiprostone—Mediastinal disorder—Etoposide—brain cancer	0.00213	0.00457	CcSEcCtD
Lubiprostone—Tachycardia—Carmustine—brain cancer	0.00212	0.00454	CcSEcCtD
Lubiprostone—Oedema—Temozolomide—brain cancer	0.0021	0.0045	CcSEcCtD
Lubiprostone—Anorexia—Carmustine—brain cancer	0.00207	0.00444	CcSEcCtD
Lubiprostone—Nausea—Procarbazine—brain cancer	0.00206	0.00442	CcSEcCtD
Lubiprostone—Nervous system disorder—Temozolomide—brain cancer	0.00206	0.00441	CcSEcCtD
Lubiprostone—Skin disorder—Temozolomide—brain cancer	0.00204	0.00437	CcSEcCtD
Lubiprostone—Hyperhidrosis—Temozolomide—brain cancer	0.00203	0.00435	CcSEcCtD
Lubiprostone—Dysgeusia—Etoposide—brain cancer	0.00201	0.00432	CcSEcCtD
Lubiprostone—Anorexia—Temozolomide—brain cancer	0.002	0.00429	CcSEcCtD
Lubiprostone—Hypersensitivity—Hydroxyurea—brain cancer	0.00198	0.00424	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Carmustine—brain cancer	0.00198	0.00424	CcSEcCtD
Lubiprostone—Muscle spasms—Etoposide—brain cancer	0.00198	0.00424	CcSEcCtD
Lubiprostone—Dyspnoea—Carmustine—brain cancer	0.00194	0.00415	CcSEcCtD
Lubiprostone—Asthenia—Hydroxyurea—brain cancer	0.00193	0.00413	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00191	0.0041	CcSEcCtD
Lubiprostone—Ill-defined disorder—Etoposide—brain cancer	0.00191	0.00409	CcSEcCtD
Lubiprostone—Decreased appetite—Carmustine—brain cancer	0.00189	0.00405	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Carmustine—brain cancer	0.00187	0.00402	CcSEcCtD
Lubiprostone—Dyspnoea—Temozolomide—brain cancer	0.00187	0.00401	CcSEcCtD
Lubiprostone—Constipation—Carmustine—brain cancer	0.00186	0.00398	CcSEcCtD
Lubiprostone—Pain—Carmustine—brain cancer	0.00186	0.00398	CcSEcCtD
Lubiprostone—Malaise—Etoposide—brain cancer	0.00186	0.00398	CcSEcCtD
Lubiprostone—Dyspepsia—Temozolomide—brain cancer	0.00185	0.00396	CcSEcCtD
Lubiprostone—Diarrhoea—Hydroxyurea—brain cancer	0.00184	0.00394	CcSEcCtD
Lubiprostone—Decreased appetite—Temozolomide—brain cancer	0.00182	0.00391	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Temozolomide—brain cancer	0.00181	0.00389	CcSEcCtD
Lubiprostone—Fatigue—Temozolomide—brain cancer	0.00181	0.00388	CcSEcCtD
Lubiprostone—Loss of consciousness—Etoposide—brain cancer	0.00181	0.00388	CcSEcCtD
Lubiprostone—Cough—Etoposide—brain cancer	0.0018	0.00385	CcSEcCtD
Lubiprostone—Pain—Temozolomide—brain cancer	0.00179	0.00385	CcSEcCtD
Lubiprostone—Constipation—Temozolomide—brain cancer	0.00179	0.00385	CcSEcCtD
Lubiprostone—Feeling abnormal—Carmustine—brain cancer	0.00179	0.00384	CcSEcCtD
Lubiprostone—Dizziness—Hydroxyurea—brain cancer	0.00178	0.00381	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Carmustine—brain cancer	0.00178	0.00381	CcSEcCtD
Lubiprostone—Chest pain—Etoposide—brain cancer	0.00175	0.00376	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00174	0.00373	CcSEcCtD
Lubiprostone—Discomfort—Etoposide—brain cancer	0.00173	0.00371	CcSEcCtD
Lubiprostone—Feeling abnormal—Temozolomide—brain cancer	0.00173	0.00371	CcSEcCtD
Lubiprostone—Abdominal pain—Carmustine—brain cancer	0.00172	0.00368	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Temozolomide—brain cancer	0.00172	0.00368	CcSEcCtD
Lubiprostone—Vomiting—Hydroxyurea—brain cancer	0.00171	0.00366	CcSEcCtD
Lubiprostone—Rash—Hydroxyurea—brain cancer	0.00169	0.00363	CcSEcCtD
Lubiprostone—Dermatitis—Hydroxyurea—brain cancer	0.00169	0.00363	CcSEcCtD
Lubiprostone—Headache—Hydroxyurea—brain cancer	0.00168	0.00361	CcSEcCtD
Lubiprostone—Abdominal pain—Temozolomide—brain cancer	0.00166	0.00356	CcSEcCtD
Lubiprostone—Tachycardia—Etoposide—brain cancer	0.00164	0.00351	CcSEcCtD
Lubiprostone—Skin disorder—Etoposide—brain cancer	0.00163	0.0035	CcSEcCtD
Lubiprostone—Hyperhidrosis—Etoposide—brain cancer	0.00162	0.00348	CcSEcCtD
Lubiprostone—Anorexia—Etoposide—brain cancer	0.0016	0.00343	CcSEcCtD
Lubiprostone—Hypersensitivity—Carmustine—brain cancer	0.0016	0.00343	CcSEcCtD
Lubiprostone—Nausea—Hydroxyurea—brain cancer	0.0016	0.00342	CcSEcCtD
Lubiprostone—Asthenia—Carmustine—brain cancer	0.00156	0.00334	CcSEcCtD
Lubiprostone—Hypersensitivity—Temozolomide—brain cancer	0.00155	0.00332	CcSEcCtD
Lubiprostone—Asthenia—Temozolomide—brain cancer	0.00151	0.00323	CcSEcCtD
Lubiprostone—Dyspnoea—Etoposide—brain cancer	0.0015	0.00321	CcSEcCtD
Lubiprostone—Diarrhoea—Carmustine—brain cancer	0.00149	0.00319	CcSEcCtD
Lubiprostone—Decreased appetite—Etoposide—brain cancer	0.00146	0.00313	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Etoposide—brain cancer	0.00145	0.00311	CcSEcCtD
Lubiprostone—Fatigue—Etoposide—brain cancer	0.00145	0.0031	CcSEcCtD
Lubiprostone—Dizziness—Carmustine—brain cancer	0.00144	0.00308	CcSEcCtD
Lubiprostone—Constipation—Etoposide—brain cancer	0.00144	0.00308	CcSEcCtD
Lubiprostone—Pain—Etoposide—brain cancer	0.00144	0.00308	CcSEcCtD
Lubiprostone—Diarrhoea—Temozolomide—brain cancer	0.00144	0.00308	CcSEcCtD
Lubiprostone—Dizziness—Temozolomide—brain cancer	0.00139	0.00298	CcSEcCtD
Lubiprostone—Feeling abnormal—Etoposide—brain cancer	0.00138	0.00297	CcSEcCtD
Lubiprostone—Vomiting—Carmustine—brain cancer	0.00138	0.00296	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Etoposide—brain cancer	0.00137	0.00294	CcSEcCtD
Lubiprostone—Rash—Carmustine—brain cancer	0.00137	0.00294	CcSEcCtD
Lubiprostone—Dermatitis—Carmustine—brain cancer	0.00137	0.00293	CcSEcCtD
Lubiprostone—Headache—Carmustine—brain cancer	0.00136	0.00292	CcSEcCtD
Lubiprostone—Vomiting—Temozolomide—brain cancer	0.00133	0.00286	CcSEcCtD
Lubiprostone—Abdominal pain—Etoposide—brain cancer	0.00133	0.00285	CcSEcCtD
Lubiprostone—Rash—Temozolomide—brain cancer	0.00132	0.00284	CcSEcCtD
Lubiprostone—Dermatitis—Temozolomide—brain cancer	0.00132	0.00283	CcSEcCtD
Lubiprostone—Headache—Temozolomide—brain cancer	0.00131	0.00282	CcSEcCtD
Lubiprostone—Nausea—Carmustine—brain cancer	0.00129	0.00277	CcSEcCtD
Lubiprostone—Nausea—Temozolomide—brain cancer	0.00125	0.00267	CcSEcCtD
Lubiprostone—Hypersensitivity—Etoposide—brain cancer	0.00124	0.00265	CcSEcCtD
Lubiprostone—Asthenia—Etoposide—brain cancer	0.0012	0.00258	CcSEcCtD
Lubiprostone—Diarrhoea—Etoposide—brain cancer	0.00115	0.00246	CcSEcCtD
Lubiprostone—Dizziness—Etoposide—brain cancer	0.00111	0.00238	CcSEcCtD
Lubiprostone—Vomiting—Etoposide—brain cancer	0.00107	0.00229	CcSEcCtD
Lubiprostone—Rash—Etoposide—brain cancer	0.00106	0.00227	CcSEcCtD
Lubiprostone—Dermatitis—Etoposide—brain cancer	0.00106	0.00227	CcSEcCtD
Lubiprostone—Headache—Etoposide—brain cancer	0.00105	0.00226	CcSEcCtD
Lubiprostone—Nausea—Etoposide—brain cancer	0.000997	0.00214	CcSEcCtD
